139 related articles for article (PubMed ID: 4717324)
21. [Defects in the prostaglandin system. VIII. A pathologic thrombocyte population in myeloproliferative syndrome, which forms no thromboxane from exogenous arachidonic acid].
Sinzinger H; Gisslinger H; Linkesch W; Ludwig H; Flener R; Peskar BA
Wien Klin Wochenschr; 1988 Nov; 100(21):715-8. PubMed ID: 3149432
[TBL] [Abstract][Full Text] [Related]
22. Platelet and plasma beta thromboglobulin in myeloproliferative syndromes and secondary thrombocytosis.
Boughton BJ; Allington MJ; King A
Br J Haematol; 1978 Sep; 40(1):125-32. PubMed ID: 81681
[TBL] [Abstract][Full Text] [Related]
23. Letter: Hyposplenism in ulcerative colitis.
Levo Y
Lancet; 1974 Nov; 2(7892):1321. PubMed ID: 4139556
[No Abstract] [Full Text] [Related]
24. Thrombocytosis and thrombocythaemia.
Murphy S
Clin Haematol; 1983 Feb; 12(1):89-106. PubMed ID: 6340888
[No Abstract] [Full Text] [Related]
25. Simultaneous study of platelets and phagocytes in myeloproliferative disorders.
Laharrague PF; Corberand JX; Fillola G; Boneu BP; Pris JF
Biomed Pharmacother; 1984; 38(9-10):462-5. PubMed ID: 6597727
[TBL] [Abstract][Full Text] [Related]
26. Characteristic changes in platelet-large cell ratio, lactate dehydrogenase and C-reactive protein in thrombocytosis-related diseases.
Kabutomori O; Kanakura Y; Iwatani Y
Acta Haematol; 2007; 118(2):84-7. PubMed ID: 17622783
[TBL] [Abstract][Full Text] [Related]
27. Classification of thrombocytosis based on platelet function tests: correlation with hemorrhagic and thrombotic complications.
Zucker S; Mielke CH
J Lab Clin Med; 1972 Sep; 80(3):385-94. PubMed ID: 5055386
[No Abstract] [Full Text] [Related]
28. Phagocytosis in myeloproliferative disorders.
Corberand J; LaHarrague P; De Larrard B; Nguyen F; Pris J
Am J Clin Pathol; 1980 Sep; 74(3):301-5. PubMed ID: 6932175
[TBL] [Abstract][Full Text] [Related]
29. Thrombocytosis and thrombocythemia: the laboratory and clinical significance of an elevated platelet count.
Davis WM; Ross AO
Am J Clin Pathol; 1973 Feb; 59(2):243-7. PubMed ID: 4510632
[No Abstract] [Full Text] [Related]
30. Alteration of platelets and virus-like particles by busulfan in myeloproliferative disorders.
Fuscaldo AA; Erlick BJ; Brodsky I; Fuscaldo KE
Leuk Res; 1980; 4(1):105-17. PubMed ID: 6157962
[No Abstract] [Full Text] [Related]
31. Thrombopoietin levels in patients with primary and reactive thrombocytosis.
Cerutti A; Custodi P; Duranti M; Noris P; Balduini CL
Br J Haematol; 1997 Nov; 99(2):281-4. PubMed ID: 9375739
[TBL] [Abstract][Full Text] [Related]
32. Primary thrombocythaemia in childhood.
Linch DC; Hutton R; Cowan D; Moore AR; Richards JD; Wilkinson LS
Scand J Haematol; 1982 Jan; 28(1):72-6. PubMed ID: 7071518
[No Abstract] [Full Text] [Related]
33. Long-term interferon therapy for thrombocytosis in myeloproliferative diseases.
Gisslinger H; Ludwig H; Linkesch W; Chott A; Fritz E; Radaszkiewicz T
Lancet; 1989 Mar; 1(8639):634-7. PubMed ID: 2564458
[TBL] [Abstract][Full Text] [Related]
34. Anagrelide for thrombocytosis in myeloproliferative disorders: a prospective study to assess efficacy and adverse event profile.
Steurer M; Gastl G; Jedrzejczak WW; Pytlik R; Lin W; Schlögl E; Gisslinger H
Cancer; 2004 Nov; 101(10):2239-46. PubMed ID: 15476273
[TBL] [Abstract][Full Text] [Related]
35. Inhibitors of fibrinolysis in platelets in polycythaemia vera and thrombocytosis.
Kwaan HC; Suwanwela N
Br J Haematol; 1971 Sep; 21(3):313-22. PubMed ID: 4255014
[No Abstract] [Full Text] [Related]
36. Acquired inhibitor of thrombin associated with an ulcerative colitis.
Granel B; Serratrice J; Disdier P; Pache X; Weiller PJ; Morange P; Juhan-Vague I
Am J Hematol; 2000 Aug; 64(4):322. PubMed ID: 10911390
[No Abstract] [Full Text] [Related]
37. Impaired expression of the thrombopoietin receptor by platelets from patients with polycythemia vera.
Moliterno AR; Hankins WD; Spivak JL
N Engl J Med; 1998 Feb; 338(9):572-80. PubMed ID: 9475764
[TBL] [Abstract][Full Text] [Related]
38. Hematopathologic findings in the myeloproliferative disorders.
Dickstein JI; Vardiman JW
Semin Oncol; 1995 Aug; 22(4):355-73. PubMed ID: 7638633
[TBL] [Abstract][Full Text] [Related]
39. [MYELOPROLIFERATIVE DISORDERS].
MARCIACQ ALTAFULLA
Arch Med Panamenos; 1963 Aug; 12():149-59. PubMed ID: 14164997
[No Abstract] [Full Text] [Related]
40. Anagrelide for control of thrombocytosis due to myeloproliferative disorders.
Harrison CN
Future Oncol; 2005 Oct; 1(5):609-18. PubMed ID: 16556037
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
